Pre-conference day

Focus day on specialty medicines

In partnership with National Healthcare Institute 
08:30

Registration and refreshments

Mr Ad Schuurman
09:00

Chair's opening remarks

Mission - why are we here? Targets and ice breakers
Mr Ad Schuurman, Head International Department, National Health Care Institute

Focus on patient access and European initiatives

Diann Potestio
09:20

Overcoming the challenges in launching a specialty product in different geographical markets

Diann Potestio, Senior Director, Market Access, West, Genzyme
Mr Patrick  Hopkinson
10:20

Examining the challenges of valuation from payers - focus on immuno-oncology therapeutic area

Mr Patrick  Hopkinson, Executive Director, WWHEOR Markets, Bristol Myers Squibb
11:00

Morning refreshments

Panel discussion
11:30

Panel discussion: Sustaining best practice and developing better access to medicines

  • Industry guidelines for developing medicines
  • Overview of European initiatives and next steps
Featuring participants from MEDEV, ADAPT SMART, MoCA and EUnetHTA

 
Solange Rohou, Senior Director of Regulatory Affairs and Policy for Europe, Astrazeneca R and D
Ann Bucsics, External Lecturer, MoCA board member, University of Vienna
12:30

Networking lunch

Mr Ad Schuurman
13:20

Chair's remarks

Mr Ad Schuurman, Head International Department, National Health Care Institute
13:25

Breakout session (part 1 of 2)

Maximising value of RWE
Practical case study session
Roleplay exercise 
 
14:50

Afternoon refreshments

Mr Ad Schuurman
15:20

Breakout session (part 2 of 2)

Developing value-added access strategies 
Practical case study session
Roleplay exercise 
Mr Ad Schuurman, Head International Department, National Health Care Institute
Mr Ad Schuurman
16:50

Breakout debrief led by Chair

Mr Ad Schuurman, Head International Department, National Health Care Institute
Mr Ad Schuurman

Chair's closing remarks

Mr Ad Schuurman, Head International Department, National Health Care Institute
last published: 01/Nov/16 11:25 GMT